6 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Overview of Treatment Agents ... Version 2.01 4/11 ... 2020 #Drugs #Medications ... #Pharmacology # ... Table #Management
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Anti-IL6 Agents ... Siltuximab) in COVID19 ... respiratory tract infection ... #Pharmacology # ... Management #Medications
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
and Pharmacology ... diarrhea & abdominal pain ... arterial thrombotic events ... #Pharmacology # ... hematology
Chronic Lymphocytic Leukemia (CLL) - Summary
Overview: 
 • Most common leukemia in adults
 • Disorder of
Complications: 1) Infection ... ) • Treatment Agents ... Lymphocytic #Leukemia #oncology ... #hematology #hemeonc ... #diagnosis #management
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
- Antithyroid medications ... salts • Chemical Agents ... Idiopathic • Infections ... Aplastic #Anemia #oncology ... #management
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
History of EBV infection ... hemolytic anemia • Pain ... express many of the genes ... classification #hematology ... #oncology #management